Early Toxicity | List of Frontiers open access articles

Original Research

Published on 20 Jan 2023

Reconstructive complications and early toxicity in breast cancer patients treated with proton-based postmastectomy radiation therapy

in Radiation Oncology

Mutlay Sayan
Lara Hathout
Sarah S. Kilic
Imraan Jan
Ambroise Gilles
Natalie Hassell
Maria Kowzun
Mridula George
Lindsay Potdevin
Shicha Kumar

Frontiers in Oncology

doi 10.3389/fonc.2023.1067500

3,098 views
7 citations

Original Research

Published on 20 May 2022

Impact of Baseline Muscle Mass and Myosteatosis on the Development of Early Toxicity During First-Line Chemotherapy in Patients With Initially Metastatic Pancreatic Cancer

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Sun Hong
Kyung Won Kim
Hyo Jung Park
Yousun Ko
Changhoon Yoo
Seo Young Park
Seungwoo Khang
Heeryeol Jeong
Jeongjin Lee

Frontiers in Oncology

doi 10.3389/fonc.2022.878472

3,376 views
15 citations

Review

Published on 30 Aug 2022

Cardiotoxicity associated with immune checkpoint inhibitors: Current status and future challenges

in Predictive Toxicology

Lu Gan
Demin Liu
Yanan Ma
Xuening Chen
Aihui Dai
Sihan Zhao
Xiaoxue Jin
Guoqiang Gu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.962596

8,360 views
25 citations

Clinical Trial

Published on 02 Apr 2019

Phase 2 Multicenter Study of Gantry-Based Stereotactic Radiotherapy Boost for Intermediate and High Risk Prostate Cancer (PROMETHEUS)

in Radiation Oncology

David Pryor
Mark Sidhom
Sankar Arumugam
Joseph Bucci
Sarah Gallagher
Joanne Smart
Melissa Grand
Peter Greer
Sarah Keats
Lee Wilton

Frontiers in Oncology

doi 10.3389/fonc.2019.00217

6,793 views
33 citations

PDF-read only

Review

Published on 23 Sep 2014

The Role of Neoadjuvant Chemotherapy in the Management of Locally Advanced Cervix Cancer: A Systematic Review

Mohammed Osman

Oncology Reviews

doi 10.4081/oncol.2014.250

Original Research

Published on 26 Nov 2014

A Phase II Study of Stereotactic Body Radiation Therapy for Low-Intermediate-High-Risk Prostate Cancer Using Helical Tomotherapy: Dose-Volumetric Parameters Predicting Early Toxicity

in Radiation Oncology

Victor A. Macias
Manuel L. Blanco
Inmaculada Barrera
Rafael Garcia

Frontiers in Oncology

doi 10.3389/fonc.2014.00336

5,568 views
20 citations

Articles

Reconstructive complications and early toxicity in breast cancer patients treated with proton-based postmastectomy radiation therapy

Impact of Baseline Muscle Mass and Myosteatosis on the Development of Early Toxicity During First-Line Chemotherapy in Patients With Initially Metastatic Pancreatic Cancer

Cardiotoxicity associated with immune checkpoint inhibitors: Current status and future challenges

Phase 2 Multicenter Study of Gantry-Based Stereotactic Radiotherapy Boost for Intermediate and High Risk Prostate Cancer (PROMETHEUS)

The Role of Neoadjuvant Chemotherapy in the Management of Locally Advanced Cervix Cancer: A Systematic Review

A Phase II Study of Stereotactic Body Radiation Therapy for Low-Intermediate-High-Risk Prostate Cancer Using Helical Tomotherapy: Dose-Volumetric Parameters Predicting Early Toxicity